Immunotherapeutic Efficacy of IgY Antibodies Targeting the Full-Length Spike Protein in an Animal Model of Middle East Respiratory Syndrome Coronavirus Infection

Identified in 2012, the Middle East respiratory syndrome coronavirus (MERS-CoV) causes severe and often fatal acute respiratory illness in humans. No approved prophylactic or therapeutic interventions are currently available. In this study, we developed chicken egg yolk antibodies (IgY Abs) specific...

Descripción completa

Detalles Bibliográficos
Autores principales: El-Kafrawy, Sherif A., Abbas, Aymn T., Sohrab, Sayed S., Tabll, Ashraf A., Hassan, Ahmed M., Iwata-Yoshikawa, Naoko, Nagata, Noriyo, Azhar, Esam I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8229159/
https://www.ncbi.nlm.nih.gov/pubmed/34073502
http://dx.doi.org/10.3390/ph14060511

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8229159/
https://www.ncbi.nlm.nih.gov/pubmed/34073502
http://dx.doi.org/10.3390/ph14060511

Ejemplares similares